InvestorsHub Logo
icon url

rafunrafun

06/20/19 11:19 AM

#197709 RE: MedResCollab #197703

MRC - But if elephants take Vascepa, the 31% RRR and CVD MOA from FOURRIER is due to patent infringement... The same hypothesis can be said of Dr. BHATT HsCRP and TG lowering, in the higher spectrum of the debacle of AdCom.

That said, the LDL levels in JELIS is due to residual risk from 25-40% statin use, as in coordination from the lower functioning lateral jigsaw embankment.

Sorry for headaches to those reading, just trying to match the logic of the post that I'm replying to!